These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7680102)

  • 61. Aflatoxin B1-induced 8-hydroxydeoxyguanosine formation in rat hepatic DNA.
    Shen HM; Ong CN; Lee BL; Shi CY
    Carcinogenesis; 1995 Feb; 16(2):419-22. PubMed ID: 7859375
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Quantitation of aflatoxin B1-DNA adducts in woodchuck hepatocytes and rat liver tissue by indirect immunofluorescence analysis.
    Zhang YJ; Chen CJ; Haghighi B; Yang GY; Hsieh LL; Wang LW; Santella RM
    Cancer Res; 1991 Mar; 51(6):1720-5. PubMed ID: 1900216
    [TBL] [Abstract][Full Text] [Related]  

  • 63. DNA damage by mycotoxins.
    Wang JS; Groopman JD
    Mutat Res; 1999 Mar; 424(1-2):167-81. PubMed ID: 10064859
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Chlorophyllin intervention reduces aflatoxin-DNA adducts in individuals at high risk for liver cancer.
    Egner PA; Wang JB; Zhu YR; Zhang BC; Wu Y; Zhang QN; Qian GS; Kuang SY; Gange SJ; Jacobson LP; Helzlsouer KJ; Bailey GS; Groopman JD; Kensler TW
    Proc Natl Acad Sci U S A; 2001 Dec; 98(25):14601-6. PubMed ID: 11724948
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Molecular dosimetry in rat urine of aflatoxin-N7-guanine and other aflatoxin metabolites by multiple monoclonal antibody affinity chromatography and immunoaffinity/high performance liquid chromatography.
    Groopman JD; Hasler JA; Trudel LJ; Pikul A; Donahue PR; Wogan GN
    Cancer Res; 1992 Jan; 52(2):267-74. PubMed ID: 1728400
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Excision of aflatoxin B1-imidazole ring opened guanine adducts from DNA by formamidopyrimidine-DNA glycosylase.
    Chetsanga CJ; Frenette GP
    Carcinogenesis; 1983 Aug; 4(8):997-1000. PubMed ID: 6409445
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Temporal patterns of covalent DNA adducts in rat liver after single and multiple doses of aflatoxin B1.
    Croy RG; Wogan GN
    Cancer Res; 1981 Jan; 41(1):197-203. PubMed ID: 7448760
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Aflatoxin B1 binding to plasma albumin and liver DNA upon chronic administration to rats.
    Wild CP; Garner RC; Montesano R; Tursi F
    Carcinogenesis; 1986 Jun; 7(6):853-8. PubMed ID: 3085966
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Quantitative analysis and chronic dosimetry of the aflatoxin B1 plasma albumin adduct Lys-AFB1 in rats by isotope dilution mass spectrometry.
    Scholl PF; McCoy L; Kensler TW; Groopman JD
    Chem Res Toxicol; 2006 Jan; 19(1):44-9. PubMed ID: 16411655
    [TBL] [Abstract][Full Text] [Related]  

  • 70. DNA adducts as exposure biomarkers and indicators of cancer risk.
    Poirier MC
    Environ Health Perspect; 1997 Jun; 105 Suppl 4(Suppl 4):907-12. PubMed ID: 9255579
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Risk assessment for aflatoxin: I. Metabolism of aflatoxin B1 by different species.
    Gorelick NJ
    Risk Anal; 1990 Dec; 10(4):539-59. PubMed ID: 2287782
    [TBL] [Abstract][Full Text] [Related]  

  • 72. In vitro binding of aflatoxin B1 and 2-acetylaminofluorene to rat, mouse and human hepatocyte DNA: the relationship of DNA binding to carcinogenicity.
    Cole KE; Jones TW; Lipsky MM; Trump BF; Hsu IC
    Carcinogenesis; 1988 May; 9(5):711-6. PubMed ID: 3130201
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Molecular dosimetry of urinary aflatoxin-DNA adducts in people living in Guangxi Autonomous Region, People's Republic of China.
    Groopman JD; Zhu JQ; Donahue PR; Pikul A; Zhang LS; Chen JS; Wogan GN
    Cancer Res; 1992 Jan; 52(1):45-52. PubMed ID: 1727385
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of multiple risk factors for hepatocellular carcinoma on formation of aflatoxin B1-DNA adducts.
    Yu MW; Lien JP; Liaw YF; Chen CJ
    Cancer Epidemiol Biomarkers Prev; 1996 Aug; 5(8):613-9. PubMed ID: 8824363
    [TBL] [Abstract][Full Text] [Related]  

  • 75. The p53 codon 249 mutational hotspot in hepatocellular carcinoma is not related to selective formation or persistence of aflatoxin B1 adducts.
    Denissenko MF; Koudriakova TB; Smith L; O'Connor TR; Riggs AD; Pfeifer GP
    Oncogene; 1998 Dec; 17(23):3007-14. PubMed ID: 9881702
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Impacts of chemicals on liver cancer risk.
    Wogan GN
    Semin Cancer Biol; 2000 Jun; 10(3):201-10. PubMed ID: 10936069
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Aflatoxin B1-2,3-oxide as a probable intermediate in the covalent binding of aflatoxins B1 and B2 to rat liver DNA and ribosomal RNA in vivo.
    Swenson DH; Lin JK; Miller EC; Miller JA
    Cancer Res; 1977 Jan; 37(1):172-81. PubMed ID: 187331
    [TBL] [Abstract][Full Text] [Related]  

  • 78. In vitro reactions of aflatoxin B1-adducted DNA.
    Groopman JD; Croy RG; Wogan GN
    Proc Natl Acad Sci U S A; 1981 Sep; 78(9):5445-9. PubMed ID: 6795633
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The enemy at the gates? DNA adducts as biomarkers of exposure to exogenous and endogenous genotoxic agents.
    Shuker DE
    Toxicol Lett; 2002 Aug; 134(1-3):51-6. PubMed ID: 12191860
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Differential mutagenicity of aflatoxin B1 in the liver of neonatal and adult mice.
    Chen T; Heflich RH; Moore MM; Mei N
    Environ Mol Mutagen; 2010 Mar; 51(2):156-63. PubMed ID: 19642212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.